Introduction {#s01}
============

Morphogenesis, cell division, wound healing, and cell motility all require the physical contraction of cell surfaces by arrays of actin and Myosin-2 (actomyosin; [@bib34]). We often equate these contractions with muscle sarcomeres, where antiparallel actin filaments (F-actin) slide toward each other via Myosin-2 motor activity. However, the contractions that power shape change in many cells defy a sarcomere-like mechanism. For example, in the actomyosin rings that divide cells during cytokinesis, F-actin is not organized in antiparallel bundles but rather forms parallel and mixed polarity bundles and even disordered networks ([@bib17]; [@bib22]; [@bib41]). Also, unlike sarcomeres, ring closure in cytokinesis has varying dependencies on Myosin-2. In some cells, reduced Myosin-2 function blocks cytokinesis ([@bib52]; [@bib25]; [@bib33]; [@bib9]). In mouse cardiomyocytes, engineered Myosin-2 that binds F-actin but lacks motor activity is sufficient to drive ring closure ([@bib26]). Finally, in budding yeast, Myosin-2 is dispensable for cytokinesis, and ring constriction is instead driven by F-actin disassembly ([@bib25]; [@bib31]). Thus, ring closure during cytokinesis involves mechanisms that extend beyond the sarcomere model. However, the molecular details of these mechanisms are poorly understood. Also, it is not clear if individual mechanisms, like Myosin-2--independent and F-actin disassembly--dependent contraction, can each stand on their own or always need to be simultaneously coupled for efficient ring closure ([@bib32]).

Here, we investigate how actomyosin rings constrict during *Drosophila melanogaster* cellularization. The fly embryo first develops as a multinucleated cell, passing through 13 nuclear divisions with no intervening cytokinesis. Finally, in cell cycle 14, the embryo undergoes cellularization, whereby ∼6,000 peripherally anchored nuclei are simultaneously packaged into a sheet of cells that goes on to gastrulate and form the hatching larva ([@bib44]). During cellularization, plasma membrane furrows invaginate from the embryo surface to build the lateral sides of cells. In three dimensions, these furrows are hollow columns of membrane that extend to enclose each nucleus ([Fig. 1 A](#fig1){ref-type="fig"}). An actomyosin ring forms at the leading edge of each membrane column and constricts perpendicular to furrows to build the bottom of each cell. The molecular composition of these rings is conserved with the contractile rings that drive cytokinesis, and cellularization resembles cytokinesis ([@bib29]; [@bib15]; [@bib28]; [@bib42]; [@bib19]). However, ring constriction in cellularization has not been described at high temporal or spatial resolution.

![**Rings constrict in distinct morphological and kinetic phases.** (A) Membrane furrows ingress during cellularization. An actomyosin ring (green) constricts to close the cell bottom. (B and C) Fixed wild-type embryos. (B) Rings in surface views (F-actin; phalloidin) at furrow lengths of 1, 4, 7, 16, 24, and 28 µm (left to right). Bar, 10 µm. (C) Ring perimeter (black) and circularity (green) versus furrow length (*n* = 56 embryos, five rings per embryo; the same trends were found in three independent experiments). Splines show trend of change for data points. Clouds show one SD from the moving mean. (D--F) Live wild-type embryos. (D) Ring perimeter versus time. Rings visualized with G-actin^Red^; see Video 1. (E) Constriction rate per phase. (F) Furrow length versus time. (A--D and F) Gray shading highlights phase 1. (D--F) *n* = 6 embryos, five rings or furrows per embryo; mean ± SE. \*, P \< 0.05.](JCB_201608025_Fig1){#fig1}

Results and discussion {#s02}
======================

Rings constrict in morphologically and kinetically distinct phases {#s03}
------------------------------------------------------------------

We tracked ring closure during cellularization in fixed wild-type embryos using phalloidin to visualize F-actin in rings ([Fig. 1 B](#fig1){ref-type="fig"}). We used increasing furrow length to order fixed embryos in developmental time because furrows ingress continuously and with highly reproducible kinetics throughout cellularization ([@bib16]). Surface views of rings revealed changes in ring perimeter and shape as embryos cellularized ([Fig. 1, B and C](#fig1){ref-type="fig"}). Shape was measured as circularity (C), where C = 1 for a circle and C \< 1 for angular shapes (e.g., C = 0.6 for a triangle; C = 4 πA/P^2^ \[A, area; P, perimeter\]; [@bib48]). Plotting ring perimeter or circularity versus furrow length per embryo revealed distinct morphological phases of constriction ([Fig. 1, B and C](#fig1){ref-type="fig"}). In an initial "assembly" phase, ring boundaries transitioned from fuzzy to sharp, and ring perimeter did not change, although ring shape morphed from circular to more angular. In constriction "phase 1", ring perimeter decreased and angular rings rounded into circles again. Finally, in constriction "phase 2", circular rings shrunk.

We next asked how rates of ring closure in live embryos map to the morphological phases seen in fixed embryos. Rings were visualized in live wild-type embryos by incorporation of injected Rhodamine G-actin (G-actin^Red^; [Fig. 1, D and E](#fig1){ref-type="fig"}; and Video 1). G-actin^Red^ injection did not obviously impede cellularization, as furrows ingressed at normal speed in these embryos ([Fig. 1 F](#fig1){ref-type="fig"}). To relate ring closure data from fixed and live imaging, we measured furrow length per embryo or furrow length per time point, respectively ([Fig. 1 F](#fig1){ref-type="fig"}). Furrow length in fixed embryos was then approximated to time within 1--2 min of error ([Fig. 1, C and D](#fig1){ref-type="fig"}; [@bib24]). Based on this analysis, the transition from phase 1 to phase 2 was seen in live data as a switch from slow to fast constriction. We calculated constriction rates in a 10-min window in the middle of each phase, avoiding data points close to the transitions. During assembly, rings constricted at −0.09 ± 0.02 µm/min (mean ± standard error \[SE\]; [Fig. 1 E](#fig1){ref-type="fig"}), consistent with little perimeter change seen in fixed data. For phase 1, rings rounded up slowly at 0.08 ± 0.01 µm/min, followed by phase 2, when circular rings constricted faster at 0.58 ± 0.02 µm/min (mean ± SE; [Fig. 1 E](#fig1){ref-type="fig"}). Thus, rings constrict during cellularization in distinct morphological and kinetic phases.

Constriction phases correlate with distinct dynamics of ring components {#s04}
-----------------------------------------------------------------------

We wondered if distinct machinery drives each phase of ring constriction. In support of this possibility, we found differences in ring composition in phase 1 versus phase 2. In cross sections from fixed embryos ([Fig. 2, A, C, E, and G](#fig2){ref-type="fig"}), we measured protein levels in rings for F-actin, Myosin-2, the F-actin bundling and bending protein Septin (*Drosophila* Peanut \[Pnut\]; [@bib1]; [@bib28]), and the Myosin-2 binding subunit of myosin phosphatase (*Drosophila* Mbs/MYPT1; [@bib37]; [@bib49]). Each protein displayed a unique profile of change in ring density with increasing furrow length, undergoing a switch in accumulation, maintenance, or depletion coincident with the onset of phase 1 and/or 2 ([Fig. 2, A--H](#fig2){ref-type="fig"}). These protein dynamics support that rings close in distinct phases. Because stoichiometric relationships differ between proteins per phase, the mechanisms that drive the phases may differ.

![**Constriction phases correlate with distinct dynamics of ring components.** (A--H) Fixed wild-type embryos. Gray shading highlights phase 1. (A, C, E, and G) Rings in cross section at increasing furrow lengths, stained for F-actin (phalloidin; A), Myosin-2 (C), Pnut (E), and Mbs (G). Arrowheads show ring position at furrow tips. Bars, 10 µm. (B, D, F, and H) Fluorescence intensity (arbitrary units \[AU\]) versus furrow length for F-actin (B), Myosin-2 (D), Pnut (F), and Mbs (H; *n* ≥ 43 embryos per staining and 10 ring profiles per embryo). Splines show trend of change for data points. Clouds show one SD from the moving mean.](JCB_201608025_Fig2){#fig2}

Myosin-2 activity is important for ring constriction in phase 1 but is largely dispensable in phase 2 {#s05}
-----------------------------------------------------------------------------------------------------

To determine the mechanisms of ring closure, we asked to what extent each phase depends on Myosin-2. To do so, we specifically inhibited Myosin-2. Normally, Rho kinase (Rok) activates Myosin-2 by phosphorylating myosin regulatory light chain (MRLC; *Drosophila* Spaghetti Squash \[Sqh\]) at threonine 20 (T20) and serine 21 (S21; [@bib2]; [@bib21]; [@bib20]). Phosphorylated MRLC/Sqh then stimulates motor ATPase activity and Myosin-2 bipolar filament formation ([@bib46]; [@bib23]). So, to block Myosin-2 activity, we used flies expressing a mutated *sqh* transgene, with T20 and S21 replaced with nonphosphorylatable alanine residues (*sqh^AA^*; [@bib49]). Control flies expressed wild-type *sqh* transgene (*sqh^WT^*). Mutant or wild-type transgenes were expressed in embryos where endogenous *sqh* levels are reduced by ∼90% (*sqh^1^* germline clones), and *sqh^AA^* embryos display embryonic phenotypes that mimic *sqh* nulls ([@bib49]).

Because the encoded Sqh^AA^ and Sqh^WT^ proteins are GFP tagged, we imaged rings in live embryos ([Fig. 3 A](#fig3){ref-type="fig"}). In *sqh^AA^* mutants, rings failed to round up in phase 1 ([Fig. 3 A](#fig3){ref-type="fig"}). The constriction rate, calculated in a 10-min window in the middle of the *sqh^AA^* phase 1, was negative, and circularity was reduced ([Fig. 3, C and D](#fig3){ref-type="fig"}). In contrast, *sqh^AA^* rings constricted at the *sqh^WT^* rate in phase 2 ([Fig. 3, A--D](#fig3){ref-type="fig"}). The switching times from phase 1 to phase 2 for *sqh^AA^* and *sqh^WT^* embryos, defined as the point of intersection between linear fits for phase 1 and 2 perimeter versus time data, were not significantly different ([Fig. 3 E](#fig3){ref-type="fig"}). To ask if perturbed Myosin-2 activity influenced F-actin disassembly, which is required for ring closure in some cells ([@bib31]), we measured F-actin turnover in G-actin^Red^--labeled rings by FRAP (Fig. S1, A--D; and Table S1). However, we found no change in the half-time to recovery (*t~1/2~*) or percent mobile fraction of F-actin in *sqh^AA^* rings ([Fig. 3 F](#fig3){ref-type="fig"} and Table S1). Although this *sqh^AA^* approach does not fully remove all Myosin-2 from embryos, our results suggest that Myosin-2 motor activity and/or F-actin cross-linking are important for constriction in phase 1 but are largely dispensable in phase 2.

![**Myosin-2 is important for constriction in phase 1, but not in phase 2.** (A--F) Live *sqh^WT^* (black) and *sqh^AA^* (green) embryos. (G--L) Live wild-type (WT; black) and *rok^2^* (pink) embryos. (A and G) Rings visualized with Sqh-GFP (A) or G-actin^Red^ (G) constricting over time (minutes). Bars, 10 µm. (B and H) Ring perimeter versus time. (C and I) Constriction rate per phase. (D and J) Circularity 40 min after cellularization onset. (E and K) Switching time from phase 1 to phase 2. (F and L) *t~1/2~* for F-actin in photobleached rings (G-actin^Red^; F, *n* ≥ 10 rings from four or more embryos per genotype; L, *n* ≥ 26 rings from ≥12 embryos per genotype; mean ± SE; see Fig. S1 and Table S1). (A, B, G, and H) Gray shading highlights phase 1 in wild-type embryos. (G) Wild-type images are the same as in [Fig. 4 A](#fig4){ref-type="fig"} and [Fig. 5 (A and G)](#fig5){ref-type="fig"}. (B--E and H--K) *n* = 6 embryos per genotype, 5 rings per embryo; mean ± SE. (C--F and I--L) \*, P \< 0.05; n.s., not significant.](JCB_201608025_Fig3){#fig3}

To confirm the varying dependencies on Myosin-2 per phase, we inhibited Myosin-2 in another way. Although less direct than targeting Myosin-2 itself, we disrupted Rok. Rok localizes to rings during cellularization ([@bib49]) and is required for Myosin-2 localization to cortical structures ([@bib43]; [@bib10]; [@bib13]; [@bib27]; [@bib49]). Accordingly, Myosin-2 was undetectable in rings in *rok* mutants (*rok^2^* germline clones; Fig. S2, A--D). To visualize rings in live *rok^2^* embryos, we injected G-actin^Red^. Similar to *sqh^AA^* results, constriction in *rok^2^* rings was inhibited in phase 1 but occurred at a rate approaching wild-type in phase 2 ([Fig. 3, G--I](#fig3){ref-type="fig"}). Because constriction in phase 1 failed, circularity remained low after phase 1 ([Fig. 3 J](#fig3){ref-type="fig"}). Consistent with *sqh^AA^*, the switching time to phase 2 and the rate of F-actin turnover did not change significantly in *rok^2^* mutants ([Fig. 3, K and L](#fig3){ref-type="fig"}). Thus, *rok* inhibition and coincident loss of Myosin-2 from rings blocked constriction in phase 1, but not phase 2.

We noted, however, that unlike *sqh^AA^* mutants, *rok^2^* embryos showed reduced ring closure speed in phase 2. We wondered if this phenotype might stem from Rok's action on downstream targets besides MRLC/Sqh, including several F-actin regulators ([@bib3]; [@bib27]). Indeed, F-actin levels in *rok^2^* mutants were reduced in phase 2 (Fig. S2 E), suggesting that the constriction mechanism in phase 2 has specific F-actin requirements.

Cofilin, but not F-actin disassembly, promotes timely switching from phase 1 to phase 2 {#s06}
---------------------------------------------------------------------------------------

To identify these F-actin requirements, we focused on the role of Cofilin. Cofilin binds and severs F-actin to promote filament disassembly and turnover ([@bib4]; [@bib30]). Cofilin-mediated F-actin disassembly is necessary for Myosin-2--independent ring constriction in budding yeast, and Cofilin modifies the spatial organization and connectivity of F-actin in rings to speed up contractility in vitro ([@bib31], [@bib32]; [@bib12]). Thus, we assayed ring closure in embryos with reduced Cofilin. We collected embryos from mothers heterozygous for a loss-of-function allele of *cofilin* (*Drosophila twinstar* \[*tsr^1^*\]; [@bib18]), thus reducing maternal Cofilin dosage by half *(1/2cofilin*). By FRAP, *1/2cofilin* embryos showed reduced F-actin disassembly in rings ([Fig. 4 F](#fig4){ref-type="fig"}; Fig. S1, E and F; and Table S1).

![**Cofilin, but not F-actin disassembly, controls timely switching to phase 2.** (A--F) Live wild-type (WT; black) and *1/2cofilin* (turquoise) embryos. (G--L) Live DMSO (control; black) and phalloidin-injected (phalloidin; red) embryos. (A and G) Rings visualized with G-actin^Red^ (A) or Sqh-GFP (G), constricting over time (minutes). Bars, 10 µm. (B and H) Ring perimeter versus time. (C and I) Constriction rate per phase. (D and J) Circularity 40 min after cellularization onset. (E and K) Switching time from phase 1 to phase 2. (F and L) *t~1/2~* (F) or percent mobile fraction (L) for F-actin in photobleached rings (G-actin^Red^; F, *n* ≥ 26 rings from ≥13 embryos per genotype; L, *n* ≥ 7 rings from ≥7 embryos per condition; mean ± SE; see Fig. S1, E--H; and Table S1). (A, B, G, and H) Gray shading highlights phase 1 in wild-type embryos. (B and H) Arrowheads indicate switching time. (H) Arrow indicates injection time. (A) Wild-type images are the same as in [Fig. 3 G](#fig3){ref-type="fig"} and [Fig. 5 (A and G)](#fig5){ref-type="fig"}. (B--E and H--K) *n* = 6 embryos per genotype or condition, five rings per embryo; mean ± SE. (C--F and I--L) \*, P \< 0.05; n.s., not significant.](JCB_201608025_Fig4){#fig4}

To visualize rings in *1/2cofilin* embryos, we used G-actin^Red^ ([Fig. 4 A](#fig4){ref-type="fig"}). We saw rings constrict in phases 1 and 2 in these embryos ([Fig. 4, B and C](#fig4){ref-type="fig"}). However, circularity was low after phase 1, reflecting reduced constriction in phase 1 ([Fig. 4, C and D](#fig4){ref-type="fig"}). In addition, fast constriction in phase 2 was significantly slower ([Fig. 4 C](#fig4){ref-type="fig"}), and switching from phase 1 to phase 2 was delayed by ∼20 min ([Fig. 4 E](#fig4){ref-type="fig"}). We interpret the latter change as a delay rather than no phase 1, because we did see slow constriction in phase 1. Interestingly, this was the first genotype to show delayed switching between constriction phases.

Because Cofilin severs and disassembles F-actin, we hypothesized that phase 1 and 2 constriction, as well as switching between them, depends on F-actin disassembly. To test this, we blocked F-actin disassembly with phalloidin. To visualize rings, embryos expressing Sqh^WT^-GFP were used and injected during ring assembly ([Fig. 4, G--L](#fig4){ref-type="fig"}). By FRAP, we confirmed that phalloidin injection stabilized F-actin ([Fig. 4 L](#fig4){ref-type="fig"}; Fig. S1, G and H; and Table S1). In fact, the percent mobile fraction of F-actin in these rings was so low that we could not reliably measure *t~1/2~* ([Fig. 4 L](#fig4){ref-type="fig"} and Table S1). However, ring constriction in phase 1 was indistinguishable from controls, and switching from phase 1 to phase 2 happened at the normal time ([Fig. 4, H--K](#fig4){ref-type="fig"}). The only change was reduced phase 2 constriction speed ([Fig. 4, H and I](#fig4){ref-type="fig"}). To make sure our results were not simply caused by a lag between phalloidin injection and its effect on constriction, we repeated the analysis, injecting phalloidin at the onset of phase 2. Again, constriction speed in phase 2 was reduced (Fig. S3, A--C). These results suggest that F-actin disassembly is not required for Myosin-2--dependent constriction in phase 1 or for timely switching from phase 1 to phase 2. However, F-actin disassembly is required for normal constriction in phase 2.

F-actin architecture may control timely switching from phase 1 to phase 2 {#s07}
-------------------------------------------------------------------------

A molecular activity of Cofilin besides F-actin disassembly seems to promote switching to the phase 2 constriction mechanism. In fact, Cofilin localization to rings is most prominent in phase 1, when F-actin is still accumulating in rings (Fig. S3, D and E). Cofilin debranches F-actin in networks to promote bundling ([@bib7]; [@bib12]), makes F-actin mechanically compliant to bending and twisting ([@bib40]; [@bib30]; [@bib11]), influences filament length via severing, and may even bundle F-actin itself ([@bib5]). These activities could cumulatively impact F-actin packing and bending in rings. Thus, we hypothesized that switching from slow to fast constriction depends on the structure and organization of F-actin in rings.

We assayed switching times in mutants where F-actin organization is known to be perturbed. Anillin (*Drosophila* Scraps/Anillin) is an F-actin cross-linking protein that localizes to rings during cellularization and cytokinesis ([@bib14]; [@bib15]; [@bib39]). For cellularization, Anillin recruits Septin/Pnut to rings, and in *anillin* mutants, F-actin forms aberrant bar-like structures in rings ([@bib15]). We prepared mutants transheterozygous for loss-of-function alleles of *anillin* (*anillin^HP/RS^*; [@bib15]), and confirmed that Septin/Pnut failed to accumulate in these rings (Fig. S2, G and H). To visualize rings in live *anillin^HP/RS^* embryos, we injected G-actin^Red^ ([Fig. 5 A](#fig5){ref-type="fig"}). Ring constriction was perturbed in both phase 1 and phase 2 in the *anillin^HP/RS^* embryos ([Fig. 5 C](#fig5){ref-type="fig"}). Most notably, switching to phase 2 was delayed by ∼20 min ([Fig. 5, B and E](#fig5){ref-type="fig"}). In contrast to *1/2cofilin* embryos, however, the delay in *anillin^HP/RS^* embryos was accompanied by little change in the rate of F-actin turnover ([Fig. 5 F](#fig5){ref-type="fig"} and Table S1). Thus, as with phalloidin, there was no correlation between reduced F-actin disassembly and delayed switching. Instead, Anillin may impact the switch via its influence over some aspect of F-actin organization.

![**Anillin and Septin control timely switching to phase 2.** (A--F) Live wild-type (WT; black) and *anillin^HP/RS^* (orange) embryos. (G--L) Live wild-type (WT; black) and *1/2pnut* (blue) embryos. (A and G) Rings visualized with G-actin^Red^ constricting over time (minutes). Bars, 10 µm. (B and H) Ring perimeter versus time. (C and I) Constriction rate per phase. (D and J) Circularity 40 min after cellularization onset. (E and K) Switching time from phase 1 to phase 2. (F and L) *t~1/2~* for F-actin in photobleached rings (G-actin^Red^; F, *n* ≥ 35 rings from ≥14 embryos per genotype; L, *n* ≥ 16 rings from ≥6 embryos per genotype; mean ± SE; see Table S1). (A, B, G, and H) Gray shading highlights phase 1 in wild-type embryos. (B and H) Arrowheads indicate switching time. (A and G) Wild-type images are the same as in [Figs. 3 G](#fig3){ref-type="fig"} and [4 A](#fig4){ref-type="fig"}. (B--E and H--K) *n* = 6 embryos per genotype and five rings were measured per embryo; mean ± SE. (C--F and I--L) \*, P \< 0.05; n.s., not significant.](JCB_201608025_Fig5){#fig5}

During cellularization, Septin/Pnut cross-links F-actin in rings into tight parallel bundles, and in vitro, Septin/Pnut promotes curvature of F-actin bundles ([@bib28]). Given that Septin/Pnut fails to localize to rings in *anillin^HP/RS^* embryos (Fig. S2, G and H; [@bib15]), we directly tested the role of Septin/Pnut in switching from phase 1 to phase 2. We collected embryos from mothers heterozygous for a loss-of-function allele of *pnut* (*pnut^02502^*; [@bib45]), reducing the maternal dose of *pnut* by half (*1/2pnut*; Fig. S2, I and J). To visualize rings in live *1/2pnut* embryos, we injected G-actin^Red^ ([Fig. 5 G](#fig5){ref-type="fig"}). Like *anillin^HP/RS^* embryos, constriction was disrupted in phases 1 and 2 in *1/2pnut* embryos ([Fig. 5, I and J](#fig5){ref-type="fig"}), and switching was delayed by ∼20 min ([Fig. 5, H and K](#fig5){ref-type="fig"}). We found no change in F-actin turnover ([Fig. 5 L](#fig5){ref-type="fig"} and Table S1). Thus, the delay is not associated with a change in F-actin disassembly. Instead, we suggest that the spatial organization of F-actin (e.g., bundling or bending) is critical for timely switching from slow to fast constriction at the transition from phase 1 to phase 2. We envision a model whereby Cofilin, Anillin, and Septin/Pnut control switching time, because they promote this optimal F-actin organization within rings.

In summary, distinct mechanisms drive back-to-back phases of actomyosin ring constriction in cellularization. These mechanisms do not require coupling, as we found genetic and pharmacological perturbations that selectively disrupted one constriction phase while leaving the other intact with its normal wild-type kinetics. To our knowledge, this is the first example where sequential and separable mechanisms of varying Myosin-2 dependencies drive one ring closure event. Adding to what is already known from other cell types, actomyosin rings seem to combine mechanisms in all possible ways, where constriction may be powered by a single mechanism or by multiple mechanisms that either overlap at the same time or occur in sequence ([@bib35]; [@bib52]; [@bib25]; [@bib41]; [@bib6]; [@bib26]; [@bib31], [@bib32]; [@bib33]; [@bib9]; [@bib36]). Per contractile event, different combinations of mechanisms may have evolved to meet specific mechanical requirements, to increase robustness, or, as suggested here, to tune the kinetics of ring closure. For cellularization, the juxtaposition of phases 1 and 2 will now allow a unique viewing of contraction mechanisms. Our data suggest that Myosin-2--dependent contraction in phase 1 and F-actin disassembly--dependent contraction in phase 2 are distinct mechanisms that can stand alone and need not overlap, as suggested by prior experiments and theory. In addition, during cellularization, F-actin disassembly--dependent contraction proceeds with little or no Myosin-2 cross-linking activity, reinforcing the need to consider roles for alternative F-actin cross-linkers in this mechanism.

Materials and methods {#s08}
=====================

Fly stocks {#s09}
----------

The wild-type stock was OreR. The *sqh^AA^*, *sqh^WT^*, and *rok^2^* germline clones were generated by standard Flipase-dominant female sterile methods with published stocks ([@bib8]; [@bib51]; [@bib50]; [@bib49]). For *sqh* germline clones, *sqh^1^*, *FRT101/FM7; sqh^AA^-gfp/CyO* or *sqh^1^, FRT101/FM7; sqh^WT^-gfp/CyO* (provided by A. Martin, Massachusetts Institute of Technology, Cambridge, MA) were crossed with *w\* ovo^D1^ v^24^ P{FRT(w^hs^)}101/C(1)DX, y^1^ f^1^/Y; P{hsFLP}38* (FBst0001813; [@bib49]). For *rok^2^* germline clones, *y^1^ w^1118^ Rok^2^ P{neoFRT}19A/FM7c* (FBst0006666) was crossed with *P{ovo^D1-18^}P4.1, P{hsFLP}12, y^1^ w^1118^ sn^3^ P{neoFRT}19A/C(1)DX, y^1^ w^1^ f^1^* (FBst0023880; [@bib51]; [@bib50]). For phalloidin injections, embryos were collected from *sqh^AX3^; sqh-gfp*, which expresses GFP-tagged wild-type Sqh in a *sqh* mutant background ([@bib43]). For manipulation of maternal dosage of Cofilin and Pnut, *1/2cofilin* and *1/2pnut* embryos were collected from *y^1^ w\*; P{FRT(w^hs^)}G13 P{A92}tsr^1^/CyO, P{sevRas1.V12}FK1* (FBst0009107) and *cn^1^ P{PZ}pnut^02502^/CyO; ry^506^* (FBst0011194) mothers, respectively. This loss-of-function strategy was previously established for F-actin regulators that are maternally provided for cellularization ([@bib53]). For *anillin* maternal effect mutants, *anillin^HP^/CyO* males and *anillin^RS^/CyO* females were crossed to generate *anillin^HP/RS^* transheterozygous females, which were crossed with *anillin^HP^/CyO* males ([@bib15]).

Embryo fixation and staining {#s10}
----------------------------

For the staining of Mbs, embryos were fixed in 16% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4)/heptane (1:1) for 20 min at room temperature. For all other stainings, embryos were fixed in 16% paraformaldehyde in PBS/heptane (1:1) for 20 min at room temperature. After both fixation methods, embryos were hand-peeled. For primary antibodies, secondary antibodies, and phalloidin, staining conditions are listed in Table S2. The Mbs antibody was a gift from C. Tan (University of Missouri, Columbia, MO).

Microinjection {#s11}
--------------

Embryos were dechorionated in 50% bleach for 1.5 min, washed with water, and mounted on their lateral side with embryo glue (heptane incubated overnight with double-stick tape). Embryos were then desiccated for 6 min, covered with halocarbon oil 700:27 (3:1), and injected at the midpoint of their ventral side as follows. For phalloidin and DMSO injection during assembly or in phase 2, the injection times were 10 min and 40 min after cellularization onset, respectively. For G-actin^Red^ injection, the injection time was 1 h before cellularization onset to allow complete diffusion throughout the embryo. Concentrations were 150 µg/ml phalloidin (EMD Millipore) in 5 mM KCl, 0.1 mM NaP, pH 7, 2% DMSO, and 5 mg/ml G-actin^Red^ (Cytoskeleton, Inc.) in 5 mM Tris-HCl, pH 8.0, 0.2 mM CaCl~2~, and 0.2 mM ATP.

Image acquisition {#s12}
-----------------

For fixed embryo imaging, single-plane images were collected on a confocal microscope (LSM710; ZEISS) using a 40× water-immersion objective, NA 1.2, with the pinhole set to one airy unit, and resolution of 1,024 × 1,024 pixels. For live-embryo imaging, the microscope and settings were the same except imaging was done on a 25°C heated stage. Mounting media was Aqua-Poly/Mount (Polysciences) for fixed embryos and halocarbon oil (Sigma-Aldrich) for live embryos. To follow constriction rates, time-lapse images were collected *en face* (i.e., in surface views) at 2.5-min intervals. This interval allowed refocusing of the imaging plane as the rings moved progressively deeper into the embryo. To follow FRAP, time-lapse images were collected in cross section at 1-s intervals. A 1-µm × 1.5-µm box, encompassing a ring in profile, was photobleached with a 561-nm laser at 100% power for 2 s, to reach ∼50% of the original fluorescence intensity. Recovery of the bleached ring was monitored for the next 150 s, until the fluorescence intensity stabilized at a plateau. Three unbleached rings were simultaneously monitored.

Image analysis {#s13}
--------------

Quantification of fluorescence intensity for ring components in fixed embryos was done with custom MATLAB code ([@bib47]), which uses thresholding to identify rings in cross section images. Rings were then hand-selected to avoid falsely identified objects, and their mean intensity was calculated. For each embryo, ∼10 rings were measured. Quantification of fluorescence intensity for FRAP was done using ImageJ.

Measurements of furrow length, ring perimeter, and ring circularity were done manually using ImageJ, except where furrow ingression rate was measured and analyzed with custom MATLAB code as previously described ([@bib16]). For fixed embryos, furrow length was measured in a cross section collected at the embryo midplane by drawing a straight line from the embryo surface to furrow tip, and the mean length was calculated from five furrows per embryo. For fixed and live embryos, perimeter and circularity were measured from surface view images by tracing the inner rim of each ring with the Polygon Tool in ImageJ, and mean values were calculated from five rings per embryo. Because fixed embryos shrink, the measurements of furrow length and perimeter were multiplied by a shrinkage factor of 1.36 for fixed embryos, which was determined by comparing the maximum furrow lengths observed from fixed and live embryos. Note that the circularity versus time profile for live wild-type embryos does not completely recapitulate the fixed circularity data. Although the overall trends of circularity change are the same for fixed and live data (i.e., rings become more circular as they constrict), the live circularity measurement does not readily detect the transitions from assembly to phase 1 or from phase 1 to phase 2. The circularity measurement displays limited sensitivity in detecting small changes in shapes that are close to circular, and rings in wild-type embryos approximate circles throughout cellularization. For live wild-types embryos, circularity values are close to one and deviate by only 2%, over all of cellularization, making it difficult to detect meaningful changes (C = 0.970 ± 0.002 or C = 0.988 ± 0.002 at the lowest or highest value near the beginning or end of cellularization, respectively; mean ± SE; *n* = 30 rings from six embryos). In addition, circularity differences are accentuated in the fixed imaging. We suggest this is because embryos shrink when fixed, and the ring morphologies seen after shrinkage reveal some underlying property of the rings. This property is likely mechanical, and may even reflect differences in the levels of tension in the rings ([@bib48]).

Data analysis {#s14}
-------------

For ring constriction rate, perimeter versus time measurements per ring were used to generate a continuous curve. Five rings were measured per embryo. All five curves from one embryo were averaged. To find the switching time between phase 1 and phase 2 per live embryo, the mean curve was fitted with a two-line model. The switching point was determined to be the point on the curve closest to the intersection of the two lines. Once the switching time was found for wild-type, *sqh^AA^-gfp*, *sqh^WT^-gfp, rok^2^*, phalloidin-injected, and DMSO-injected embryos, the ring constriction rate of each phase was calculated by averaging the derivative of the perimeter curves within a 10-min time window per phase. The phase 1 window was set to end 5 min before the switching point, and the phase 2 window was set to start 8 min after the switching point. For *1/2cofilin*, *anillin^HP/RS^*, and *1/2pnut* embryos, where switching was delayed, the phase 2 window was set the same way as for all other genotypes; however, the phase 1 window was set from 30 to 40 min after cellularization onset, which is the wild-type phase 1 time range.

For change in ring size, shape, and fluorescence intensity versus furrow length for fixed embryos, the mean perimeter, circularity, or intensity value for each embryo was plotted against the mean furrow length of that embryo. Plots were generated using the "curve fitting tool" in MATLAB, according to the "smoothing spline" method with the smoothing parameter P = 0.05. The shaded region around the spline was generated by calculating the standard deviation of all data points within a 10-µm-wide bin centered on any given furrow length, with ∼30 overlapping bins moving along the x axis.

For FRAP, the fluorescence intensity of the bleached ring (I~frap~) and the mean intensity of three reference unbleached rings (I~ref~) were normalized by using the Phair's double normalization ([@bib38]): I~norm~ = (I~frap~/I~frap-pre~)/(I~ref~/I~ref-pre~), where I~frap-pre~ and I~ref-pre~ are two constants, representing the prebleach intensity of I~frap~ and I~ref~, respectively, and I~norm~ is the normalized intensity of the bleached ring. The I~norm~ versus time curve was then fitted with a single exponential equation: I~norm~ = I~∞~ − (I~∞~ − I~0~) × e^(−k\ ×\ t)^, where t represents time and t = 0 is the end of bleaching, I~0~ = I~norm~ (t = 0), I~∞~ = I~norm~ (t = ∞), and k is the reaction rate constant of the intensity recovery process. Therefore, the half-time to recovery was calculated by *t~1/2~* = ln(2)/k, and the mobile fraction was calculated by mobile fraction = (I~∞~ − I~0~)/(1 − I~0~). A small number of rings were discarded from the analysis if the fit had an *r*^2^ \< 0.6.

Statistics {#s15}
----------

P-values were calculated using the two-tailed unpaired Student's *t* test, with equal variances. All error bars are mean ± SE.

Online supplemental material {#s16}
----------------------------

Fig. S1 shows that F-actin in rings turns over throughout cellularization, but turnover (i.e., disassembly) is reduced in *1/2cofilin* and phalloidin-injected embryos. Fig. S2 shows disruption of various ring components in *rok^2^*, *anillin^HP/RS^*, and *1/2pnut* embryos. Fig. S3 shows that phalloidin injection at the onset of phase 2 slows down ring constriction in phase 2 and that Cofilin localization to rings is most prominent in phase 1. Video 1 shows ring constriction in a wild-type embryo, visualized by injection of G-actin^Red^. Table S1 contains the *t~1/2~* values and percent mobile fraction for F-actin in rings from all FRAP experiments. Table S2 contains the staining conditions for antibodies and probes.
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